Diabetes drug metformin recalled over high levels of cancer contaminant
Category: #health  By Nikita Chaurasia  Date: 2020-10-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

Diabetes drug metformin recalled over high levels of cancer contaminant

Metformin hydrochloride, a widely used diabetes drug, has reportedly been recalled after manufacturers detected high levels of cancer-causing contaminant in it. According to reliable sources, the latest recall by the U.S. Food & Drug Administration (FDA) involves two India-based companies, Sun Pharmaceutical Industries Ltd. and Marksans Pharma Ltd.

The drug is produced at Sun Pharma’s Mohali-based manufacturing facility and is being recalled by its subsidiary in the United States, sources claimed. Moreover, the recall pertains to 500 mg and 700 mg metformin tablets which are sold under the name of Time-Cap Labs Inc.

For those uninitiated, metformin tablets are utilized to treat patients with type 2 diabetes and help in reducing glucose levels. In this context, the FDA mentioned in a comment that patients consuming metformin products should continue taking the medication until a pharmacist or a doctor prescribes a replacement.

The manufacturers are recalling the diabetes drug owing to deviation from the CGMP (current good manufacturing practices) and detection of NDMA (N-nitrosodimethylamine) impurity in the final product, the FDA claimed.

It is to be noted that FDA has been exploring the presence of nitrosamines, a potential carcinogen, among popular diabetes drugs since December last year. However, the agency stated that the source and the risk of nitrosamines in these medications is still unknown.

As per the reports, the FDA has informed various drug manufacturers to test their respective products before dispatching into the market. In addition, the agency should be notified if any product displays high levels of nitrosamines.

In other news, Sunshine Mills has reportedly issued an extended recall of its dog food after the company discovered high levels of aflatoxin, which according to the FDA, is a mold byproduct that can be harmful for pets if consumed in high quantities.

Source Credits –

https://newyork.cbslocal.com/2020/10/11/diabetes-drug-metformin-recall/

https://www.thesun.co.uk/news/12903411/diabetes-metformin-hydrochloride-recall-cancer/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Syndax Pharmaceuticals reveals data from phase 1 trial of axatilimab
Syndax Pharmaceuticals reveals data from phase 1 trial of axatilimab
By Nikita Chaurasia

According to reliable sources, Massachusetts-headquartered clinical stage biopharmaceutical company, Syndax Pharmaceuticals Inc. has revealed an updated data from its Phase 1 trial of its patent axatilimab. The company will reportedly present the dat...

Xiaomi shares drop by 7.1% after raising USD 3.9 billion in equity deal
Xiaomi shares drop by 7.1% after raising USD 3.9 billion in equity deal
By Nikita Chaurasia

Shares of Xiaomi Corporation, a Chinese multinational electronics company, witnessed a 7.1% drop during Hong Kong trading after the company secured USD 3.91 billion in fund raising which also included the city’s top-up placement. The company h...

Supercom signs a supply contract of PureSecurity EM suite in Wisconsin
Supercom signs a supply contract of PureSecurity EM suite in Wisconsin
By Nikita Chaurasia

Israel-based leading provider of advanced solutions for cybersecurity, IoT (Internet of Things) and e-Government sectors Supercom has reportedly signed a supply agreement to deliver its PureSecurity EM (Electronic Monitoring) product suite in Wiscons...